InvestSMART

PainChek Ltd (ASX: PCK) - Announcements

- Current share price for PCK : $0.105

ASX company news and announcements for PainChek Ltd (PCK) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PainChek Ltd (PCK) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PainChek Ltd (PCK), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PainChek Ltd (PCK)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$22 Application for quotation of securities - PCK 6 Mar 2025 9:42AM $0.030 $0.105 risen by 250%
$22 Notification regarding unquoted securities - PCK 5 Mar 2025 3:47PM $0.030 $0.105 risen by 255.93%
$22 Half Yearly Report and Accounts 28 Feb 2025 8:09AM $0.032 $0.105 risen by 228.13%
$22 Results of Meeting 26 Feb 2025 4:51PM $0.033 $0.105 risen by 218.18%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 8:24AM $0.028 $0.105 risen by 275%
$22 Quarterly update and Appendix 4C webinar 30 Jan 2025 9:45AM $0.027 $0.105 risen by 288.89%
$22 Notice of General Meeting/Proxy Form 24 Jan 2025 10:28AM $0.027 $0.105 risen by 288.89%
$22 Notification of cessation of securities - PCK 24 Dec 2024 10:54AM $0.026 $0.105 risen by 303.85%
$22 Change of Director's Interest Notice x5 23 Dec 2024 10:40AM $0.025 $0.105 risen by 320%
$22 Notification regarding unquoted securities - PCK 19 Dec 2024 10:59AM $0.026 $0.105 risen by 303.85%
$22 Application for quotation of securities - PCK 19 Dec 2024 10:58AM $0.026 $0.105 risen by 303.85%
$22 PainChek completes Entitlement Offer raising AUD $5.1 m 16 Dec 2024 11:39AM $0.026 $0.105 risen by 303.85%
$22 PainChek Implementations, Market and International Expansion 11 Dec 2024 8:21AM $0.027 $0.105 risen by 288.89%
$22 PainChek Entitlement Offer Open 2 Dec 2024 9:58AM $0.028 $0.105 risen by 275%
$22 Results of Meeting 28 Nov 2024 6:02PM $0.028 $0.105 risen by 275%
$22 PCK AGM watching the live feed 27 Nov 2024 2:11PM $0.027 $0.105 risen by 288.89%
$22 Proposed issue of securities - PCK 25 Nov 2024 9:52AM $0.028 $0.105 risen by 275%
$22 Prospectus 25 Nov 2024 9:52AM $0.028 $0.105 risen by 275%
$22 Underwritten Entitlement Offer to raise AUD $5.1million 25 Nov 2024 9:51AM $0.028 $0.105 risen by 275%
$22 Trading Halt 21 Nov 2024 9:10AM $0.028 $0.105 risen by 275%
$22 PCK submits application for Adult App FDA De Novo clearance 20 Nov 2024 8:21AM $0.028 $0.105 risen by 275%
$22 Addendum to BESTMED reseller agreement announcement 19 Nov 2024 10:31AM $0.029 $0.105 risen by 262.07%
$22 PCK expands market reach with BESTMED reseller agreement 13 Nov 2024 8:44AM $0.028 $0.105 risen by 275%
$22 Quarterly Investor Presentation 30 Oct 2024 8:29AM $0.034 $0.105 risen by 208.82%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2024 8:27AM $0.034 $0.105 risen by 208.82%

101 - 125 of 470 results

Page 5 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.